Zanamivir is indicated for the treatment of uncomplicated acute illness due to influenza infections in adults and children aged 7 years and older who have been symptomatic for no more than two days. It is also used prophylactically to prevent influenza in individuals aged 5 years and older. The drug is particularly useful during influenza outbreaks in communities, schools, and other closed environments.
